Skip to main content

Table 2 Clinical characteristics of study populationa

From: A preliminary evaluation of influence of body mass index on in vitro fertilization outcome in non-obese endometriosis patients

 

Body mass index groups

p value

 

Underweight

Normal weight

Overweight

Basal E2 (pmol/ml)

191.58 ± 104.97

194.79 ± 180.48

220.56 ± 177.41

0.779

Basal FSH (mIU/ml)

7.22 ± 2.95

7.65 ± 2.86

7.22 ± 3.84

0.259

AMH (ng/ml)

1.46 ± 1.21

1.84 ± 1.61

2.21 ± 1.76

0.447

AFC

9.8 ± 3.51

11.6 ± 6.03

10.76 ± 5.32

0.742

Infertility duration

6.5 ± 3.35

7.03 ± 3.32

8.18 ± 4.2

0.272

Endometriosis

 Grade I

2 (12.5%)

33 (29.73%)

16 (55.17%)

<0.001§

 Grade II

2 (12.5%)

24 (21.62%)

9 (31.03%)

 Grade III

7 (43.75%)

41 (36.94%)

4 (13.80%)

 Grade IV

5 (31.25%)

13 (11.71%)

0 (0%)

Infertility type

 Primary

14 (87.5%)

88 (79.27%)

21 (72.4%)

0.484

 Secondary

2 (12.5%)

23 (20.72%)

8 (27.58%)

Surgical treatment for endometriosis

 None

1 (6.25%)

28 (25.22%)

13 (44.82%)

0.048

 Electrocoagulation

4 (25%)

12 (10.81%)

7 (24.13%)

 Cystectomy

4 (25%)

41 (36.93%)

5 (17.24%)

 Bilateral cystectomy

3 (18.75%)

9 (8.1%)

1 (3.44%)

 Cystotomy

2 (12.5%)

12 (10.81%)

1 (3.44%)

 Bilateral cystotomy

2 (12.5%)

9 (8.1%)

2 (6.89%)

Endometrioma

 None

9 (56.25%)

72 (64.87%)

23 (79.31%)

0.083

 Unilateral

4 (25%)

33 (29.73%)

6 (20.69%)

 Bilateral

3 (18.75%)

6 (5.40%)

0 (0%)

  1. aData are presented as mean ± SD or counts (%). Kruskal-Wallis test. Chi-square test. §Chi-square test for trend